Reposted by Dylan Reid
Tiny startup Nabla Bio posted a preprint Thursday highlighting its progress in creating antibodies from scratch that look therapeutically viable against some hard-to-drug targets in what it’s calling a first for the field.
endpts.com/nabla-bio-mo...
endpts.com/nabla-bio-mo...
Surrounded by AI bio giants, tiny startup Nabla Bio makes de novo antibodies look more like drugs
Protein-making AI models have fueled the launch of a $1 billion startup and a Nobel Prize win in 2024, but are they ready to actually make drugs? Leaders of some ...
endpts.com
November 22, 2024 at 2:12 PM
Tiny startup Nabla Bio posted a preprint Thursday highlighting its progress in creating antibodies from scratch that look therapeutically viable against some hard-to-drug targets in what it’s calling a first for the field.
endpts.com/nabla-bio-mo...
endpts.com/nabla-bio-mo...